Publication | Closed Access

Dihydromyricetin improves glucose and lipid metabolism and exerts anti-inflammatory effects in nonalcoholic fatty liver disease: A randomized controlled trial

ObesityMetabolic SyndromeHepatologyLipid MetabolismMedicineLiver PhysiologyDiabetesAnti-inflammatory EffectsMetabolic ComplicationLiver DiseaseFatty Liver DiseaseMetabolismPharmacologyHealth Sciences